Inflammatory Parameters as Available Prognostic Factors for Pancreatic Cancer after Chemoradiotherapy

참고문헌 (10)

1. Siegel RL, "Cancer statistics, 2017", CA Cancer J Clin, 67, pp.7~30 (2017)[DOI]
2. Alexakis N, "Current standards of surgery for pancreatic cancer", Br J Surg, 91, pp.1410~1427 (2004)[DOI]
3. James TA, "Risk factors associated with earlier age of onset in familial pancreatic carcinoma", Cancer, 101, pp.2722~2726 (2004)[DOI]
4. Kamisawa T, "Pancreatic cancer", Lancet, 388, pp.73~85 (2016)[DOI]
5. Balkwill FR, "Cancer-related inflammation: common themes and therapeutic opportunities", Semin Cancer Biol, 22, pp.33~40 (2012)[DOI]
6. McMillan DC, "The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer", Cancer Treat Rev, 39, pp.534~540 (2013)[DOI]
7. Byung Min Lee, "The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy", Gut and Liver, 12(3), pp.342~352 (2018), 거트앤리버 소화기연관학회협의회
8. Templeton AJ, "Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis", J Natl Cancer Inst, 106, pp.dju124~ (2014)
9. Zhou Y, "Prognostic role of the neutrophil-to-lymphocyte ratio in pancreatic cancer: a metaanalysis containing 8252 patients", Clin Chim Acta, 479, pp.181~189 (2018)[DOI]
10. Xu ZS, "Prognostic role of the pretreatment platelet-lymphocyte ratio in pancreatic cancer: a metaanalysis", Oncotarget, 8, pp.99003~99012 (2017)

관련 논문AI추천